FENGBEI BIOTECH
60333433.733.56% ( +1.16 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: FENGBEI BIOTECH(603334) the Revenue is 1.109 B (+66.55%);the EBIT is 49.29 M (+22.36%);the EPS is 0.28 (-17.65%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
1.11B66.55%
----
----
EBIT
0.05B22.36%
----
----
EPS
0.2817.65%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf